Immunotherapeutics and other anticancer agents in the management of advanced gastric cancer

Advanced gastric cancer (AGC) is characterized by high mortality. The survival is estimated as 14.2 months. The treat­ment of choice in the early stages of GC is surgery. Due to high potential of malignancy, postoperative chemotherapy is usually administered. Novel methods of treatment involve immun...

Full description

Bibliographic Details

Published in:	Nowotwory
Main Authors:	Kajetan Kiełbowski, Estera Bakinowska, Przemysław Dymek, Sandra Sienkiewicz, Tomasz Błaszkowski, Maciej Romanowski
Format:	Article
Language:	English
Published:	Via Medica 2022-10-01
Subjects:	advanced gastric cancer immunotherapeutic agents monoclonal antibodies immune checkpoint inhibitors
Online Access:	https://journals.viamedica.pl/nowotwory_journal_of_oncology/article/view/90560